Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Liquidia Corp

Get SEC filing alerts via email and in your feed for Liquidia Corp

LQDA

Liquidia Corp

About Liquidia Corp

Liquidia Corporation is a biopharmaceutical company specializing in developing, manufacturing, and commercializing innovative therapies for rare cardiopulmonary diseases like pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Utilizing its proprietary PRINT particle engineering technology, the company creates targeted inhaled and injectable drug formulations, focusing on improving safety, efficacy, and patient convenience through novel delivery systems and strategic partnerships.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Liquidia Corp

1
1
Liquidia Corp Liquidia Corporation Reports $132.9 Million Revenue in Latest Quarter, Driven by YUTREPIA Launch

Via official filing (AI summary) | 25 days ago | 0 comments

2
1
Liquidia Corp Liquidia Corporation Reports $158.3 Million Revenue and Launch of YUTREPIA in 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Liquidia Corp Liquidia Corporation Reports $54.3 Million Revenue and $3.5 Million Net Loss for Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Liquidia Corp Liquidia Corporation Reports Q2 2025 Financial Results with Revenue Growth from YUTREPIA Launch

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Liquidia Corp Liquidia Corporation Reports Q1 2025 Financial Results with Revenue Increase and Higher Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Liquidia Corp Liquidia Corporation Reports $130.4 Million Net Loss and Decreased Revenue for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Liquidia Corp Liquidia Corporation Reports 21% Q3 Revenue Growth, Significant Expenses Increase, and Strategic Developments

Via official filing (AI summary) | over 1 year ago | 0 comments